Arie Belldegrun
Fondateur chez KRONOS BIO, INC.
Fortune : 32 M $ au 31/05/2024
Profil
Arie S. Belldegrun est un entrepreneur et un homme d'affaires qui a fondé 6 sociétés, parmi lesquelles : Kite Pharma, Inc., Allogene Therapeutics, Inc. et Agensys, Inc. et qui a été à la tête de 16 sociétés différentes. Actuellement, il occupe le poste de président et associé de Two River Group Holdings LLC, président de Two River Group Management LLC, président de Bellco Capital LLC (qu'il a fondée en 2003), président de Two Rivers Consulting Corp, président d'UroGen Pharma Ltd, président et associé de Two River Consulting LLC, président exécutif d'Allogene Therapeutics, Inc. (qu'il a fondée en 2017), président de Kronos Bio, Inc, coprésident de Breakthrough Properties LLC, directeur général principal de VV Manager LLC (qu'il a fondée en 2017), directeur général principal de Vida Ventures LLC (qu'il a fondée en 2017) (une filiale de VV Manager LLC) et président de Technology Assessment Group. Arie S. Belldegrun est également directeur et professeur à l'Institut d'oncologie urologique de l'UCLA, chef de la division d'oncologie urologique de la David Geffen School of Medicine et directeur général principal chez Vida Ventures LLC (qu'il a fondé en 2017) et siège au conseil d'administration de 5 autres sociétés. Le Dr Belldegrun était auparavant président du conseil d'administration d'Arno Therapeutics, Inc. et président non exécutif chez Arno Therapeutics, Inc. (une filiale d'Arno Therapeutics, Inc.), président du conseil d'administration, président et directeur général d'Equinor ASA, directeur d'Agensys, Inc. (il a fondé la société en 1997), président exécutif, président et PDG de Kite Pharma, Inc. (qu'il a fondée en 2009), président du comité de technologie biologique moléculaire de l'American Urological Association Education & Research, Inc. et chercheur à l'Institut national du cancer, ainsi que membre du Los Angeles Economy & Jobs Committee. Arie S. Belldegrun a obtenu un doctorat de la faculté de médecine Hadassah de l'Université hébraïque et un diplôme d'études supérieures de l'Institut Weizmann des sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/05/2024 | 10 099 279 ( 4,84% ) | 25 M $ | 31/05/2024 | |
UROGEN PHARMA LTD.
1,13% | 07/09/2023 | 408 693 ( 1,13% ) | 5 M $ | 31/05/2024 |
KRONOS BIO INC
1,13% | 31/03/2024 | 679 575 ( 1,13% ) | 536 864 $ | 31/05/2024 |
| 10/04/2024 | 589 662 ( 0,03% ) | 311 931 $ | 31/05/2024 |
Postes actifs de Arie Belldegrun
| Sociétés | Poste | Début |
|---|---|---|
| UROGEN PHARMA LTD. | Président | 01/10/2012 |
| ALLOGENE THERAPEUTICS, INC. | Fondateur | 01/11/2017 |
| KRONOS BIO, INC. | Fondateur | 01/11/2017 |
| GINKGO BIOWORKS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/01/2021 |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/10/2019 |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
| Breakthrough Services LLC | Président | 01/04/2019 |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA. | Fondateur | 01/01/2004 |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Fondateur | 01/06/2020 |
| ░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Arie Belldegrun
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Arie Belldegrun
| Weizmann Institute of Science | Graduate Degree |
| The Hebrew University Hadassah Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| EQUINOR ASA | Energy Minerals |
| ARNO THERAPEUTICS, INC. | Health Technology |
| UROGEN PHARMA LTD. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| GINKGO BIOWORKS HOLDINGS, INC. | Health Services |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 31 |
|---|---|
| Email Real Estate.com, Inc. | Finance |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Finance |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Paramount Acquisition Corp. was incorporated in Delaware on June 1, 2005 as a blank check company with a objective to acquire an operating business. It is a newly organized Specified Purpose Acquisition Company. The purpose of its incorporation is effecting a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business in the healthcare industry. | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
| Arno Therapeutics, Inc. /Old/ | Health Technology |
Technology Assessment Group
 Technology Assessment Group Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Technology Assessment Group provides research and evaluation services for the effects of drug therapies. The company is based in San Francisco, CA. Technology Assessment Group was acquired by Quintiles Transnational Corp. on February 09, 1998. | Commercial Services |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
American Urological Association Education & Research, Inc.
 American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services American Urological Association Education & Research, Inc. operates a urologic association. It offers urological clinical care through education, research and the formulation of health care policy. The company was founded on February 22, 1902 and is headquartered in Linthicum, MD. | Commercial Services |
| Los Angeles Economy & Jobs Committee | |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Health Technology |
| Bioscience for the State of California | |
Bellco Capital LLC
Bellco Capital LLC Investment ManagersFinance Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA. | Finance |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| UCLA Institute of Urologic Oncology | |
| The American Association of Genitourinary Surgeons | |
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Ginkgo Bioworks, Inc. engages in the development of microbe for different applications. Its organisms can be used for fuels, flavorings, fragrances, cosmetics, and pharmaceutical products. The company was founded by Thomas F. Knight Jr., Austin Che, Reshma Shetty, Bartholomew Canton and Jason Kelly in 2008 and is headquartered in Boston, MA. | Technology Services |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Finance |
ByHeart, Inc.
ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Commercial Services |
105 W First Street LLC
105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Finance |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Finance |
| Breakthrough Services LLC | |
IconOVir Bio, Inc.
IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Health Technology |
Soaring Eagle Acquisition Corp.
 Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Soaring Eagle Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jeffrey Franklin Sagansky, Eli Baker and Harry Evans Sloan on October 22, 2020 and is headquartered in New York, NY. | Finance |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Finance |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
